New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination
Abstract The COVID‐19 mRNA vaccines not only provide remarkable protection but also have been characterized by an overall safe and well‐tolerated side effect profile. Herein, we discuss a rare but manageable cutaneous reaction to COVID vaccination in order to further characterize dermatologic reacti...
Main Authors: | Joshua Kaminetsky, Donald Rudikoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.4865 |
Similar Items
-
Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
by: Oleguer Parés-Badell, et al.
Published: (2022-07-01) -
Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
by: Suresh Babu Chellapandian, et al.
Published: (2022-04-01) -
Guillain‐Barré syndrome after mRNA‐1273 (Moderna) COVID‐19 vaccination: A case report
by: Zauraiz Anjum, et al.
Published: (2022-04-01) -
New-onset chilblains in close temporal association to mRNA-1273 vaccination
by: Connie Kha, MD, et al.
Published: (2021-06-01) -
Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination
by: Sun Hye Shin, et al.
Published: (2022-01-01)